Patent Assignment
Reel/Frame 069094/0247
Assignment of Assignor's Interest
Recorded: 2024-10-01
Pages: 9
Assignors
XU, YONG
Executed: 2014-01-28
BRENNING, BENJAMIN GARY
Executed: 2014-04-30
KULTGEN, STEVEN G.
Executed: 2014-01-28
LIU, XIAOHUI
Executed: 2014-02-05
SAUNDERS, MICHAEL
Executed: 2014-03-12
HO, KOC-KAN
Executed: 2014-04-07
Assignee
TOLERO PHARMACEUTICALS, INC.
2975 W. EXECUTIVE PARKWAY, SUITE 320, LEHI, UTAH, 84043
Covered Property
(1)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application:
18/741,526 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Change of Name
Oct 1, 2024
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0417 →
Change of Name
Oct 1, 2024
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0505 →
Merger
Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068758/0057 →
Merger
Oct 1, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068758/0193 →